OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Post hoc Analysis of a Randomized, Controlled, Phase 2 Study to Assess Response Rates with Chlormethine/Mechlorethamine Gel in Patients with Stage IA–IIA Mycosis Fungoides
Christiane Querfeld, Julia Scarisbrick, Chalid Assaf, et al.
Dermatology (2021) Vol. 238, Iss. 2, pp. 347-357
Open Access | Times Cited: 16

Showing 16 citing articles:

EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome – Update 2023
Johanna Latzka, Chalid Assaf, M. Bagot, et al.
European Journal of Cancer (2023) Vol. 195, pp. 113343-113343
Open Access | Times Cited: 66

Chlormethine Gel for Patients with Mycosis Fungoides Cutaneous T Cell Lymphoma: A Review of Efficacy and Safety in Clinical Trial and Real-World Settings
Ulrike Wehkamp, Marco Ardigò, Evangelia Papadavid, et al.
Advances in Therapy (2022) Vol. 39, Iss. 9, pp. 3979-4002
Open Access | Times Cited: 15

Response to Chlormethine/Mechlorethamine gel Maintenance Treatment Regimen in Patients With Mycosis Fungoides: A Single-center Retrospective Study
Emily Correia, Shalini Krishnasamy, Jayson G. Suriano, et al.
Clinical Lymphoma Myeloma & Leukemia (2022) Vol. 22, Iss. 8, pp. 581-588
Closed Access | Times Cited: 13

Advances in the pharmacological management of cutaneous T-cell lymphoma
Gabriele Roccuzzo, A Roggo, Egle Ramelyte, et al.
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 7, pp. 885-894
Closed Access | Times Cited: 2

Increased Chlormethine-Induced DNA Double-Stranded Breaks in Malignant T Cells from Mycosis Fungoides Skin Lesions
Yun‐Tsan Chang, Desislava Ignatova, Wolfram Hoetzenecker, et al.
JID Innovations (2021) Vol. 2, Iss. 1, pp. 100069-100069
Open Access | Times Cited: 13

The optimal use of chlormethine gel for mycosis fungoides: An expert consensus from Germany, Austria and Switzerland (DACH region)
Chalid Assaf, Nina Booken, Edgar Dippel, et al.
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2022) Vol. 20, Iss. 5, pp. 579-586
Open Access | Times Cited: 9

Chlormethine gel is effective for the treatment of skin lesions in patients with early‐ and late‐stage mycosis fungoides in clinical practice
Evangelia Papadavid, Marios Koumourtzis, Vasiliki Nikolaou, et al.
Journal of the European Academy of Dermatology and Venereology (2022) Vol. 36, Iss. 10, pp. 1751-1757
Closed Access | Times Cited: 9

Mechanism of action of chlormethine gel in mycosis fungoides
Emmanuella Guenova, Pablo L. Ortiz‐Romero, Brian Poligone, et al.
Journal of the European Academy of Dermatology and Venereology (2023) Vol. 37, Iss. 9, pp. 1739-1748
Open Access | Times Cited: 5

Real-life experience with chlormethine gel for early-stage mycosis fungoides with emphasis on types and management of cutaneous side-effects #
Hadas Prag Naveh, Iris Amitay‐Laish, Omri Zidan, et al.
Journal of Dermatological Treatment (2021) Vol. 33, Iss. 4, pp. 2364-2370
Closed Access | Times Cited: 12

Chlormethine Gel Versus Chlormethine Ointment for Treatment of Patients with Mycosis Fungoides: A Post-Hoc Analysis of Clinical Trial Data
Christiane Querfeld, Julia Scarisbrick, Chalid Assaf, et al.
American Journal of Clinical Dermatology (2022) Vol. 23, Iss. 4, pp. 561-570
Open Access | Times Cited: 6

Chlormethin‐Gel zur Behandlung der Mycosis fungoides: Ein Expertenkonsens aus Deutschland, Österreich und der Schweiz (DACH‐Region) zum Therapiemanagement
Chalid Assaf, Nina Booken, Edgar Dippel, et al.
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2022) Vol. 20, Iss. 5, pp. 579-588
Open Access | Times Cited: 6

Prior Bexarotene or Phototherapy Does Not Affect Response to Chlormethine Gel: Post Hoc Analysis of a Pivotal Trial
Chalid Assaf, Christiane Querfeld, Marta Scandurra, et al.
Acta Dermato Venereologica (2023) Vol. 103, pp. adv00862-adv00862
Open Access | Times Cited: 2

Chlormethine Gel for Treatment of Patients with Mycosis Fungoides: Best Practices and Guidance to Clinicians
Larisa J. Geskin, Christiane Querfeld, Emmilia Hodak, et al.
Dermatology and Therapy (2024)
Open Access

Mycosis fungoides and Sezary syndrome – Simplifying the approach for dermatologists. Part 2: Evaluation, staging, prognosis and treatment
Gautam Kumar Singh, Pankaj Das, Sarita Srivastava, et al.
Indian Journal of Dermatology Venereology and Leprology (2024), pp. 1-8
Open Access

New developments in skin-directed treatments of cutaneous T-cell lymphoma
Iris Amitay‐Laish, Emmilia Hodak
La Presse Médicale (2022) Vol. 51, Iss. 1, pp. 104125-104125
Closed Access | Times Cited: 1

Mechlorethamine Hydrochloride Gel in the Treatment of Mycosis Fungoides–Type Cutaneous T-Cell Lymphoma (MF-CTCL): A Focus on Patient Selection and Special Considerations
Caitlin Crimp, Ameya Gangal, Erica S. Tarabadkar, et al.
Cancer Management and Research (2022) Vol. Volume 14, pp. 3271-3279
Open Access | Times Cited: 1

Page 1

Scroll to top